A CRISPR-Cas9 Research and the GDPR. A case-study

Personal genetic data processing is routinely believed to be subjected to Data Protection Regulations and in particular to the EU General Data Protection Regulation. While this is – in general – true, it is important to know exactly when and until where those regulation can affect the genetic research and – therefore – the possibility to find a cure for genetic diseases. Clearly, an actual life-or-death problem. Continue reading “A CRISPR-Cas9 Research and the GDPR. A case-study”

Playing God. CRISPR and the re-shaping of fundamental rights

I just came back from Japan where I gave a few lectures on data protection, computer forensics and genetics. I addressed this last topic at Tokyo’s Keio University with a talk titled “Playing God. CRISPR and the re-shaping of fundamental rights“.

This is the agenda (the transcript is coming…):

Agenda 議題

Molecular Biology and Bioinformatics Basics


CRISPR – A Step Ahead


Law, Science, Religion

法則, 科学, 宗教

Can Life be Owned?


Copyright: a New Cage

Copyright: 新しい檻

Who Owns (Bio) information


Genetics, Privacy and Data Protection

遺伝学, 内証, 情報の保護

Freedom of Research


Criminal Investigations and Trials


National DNA Database and Public Policing




Upcoming Data Protection Regulation to Hampers Genetic and Pharmaceutical Research

The privacy hysteria that since twenty or so years affects policy makers and data protection authorities, reached a new peak with the upcoming data protection regulation whose text has been published last Dec, 18, 2015.

While, thanks God, the text clearly states that “biosample” as such aren’t “personal data”

genetic data should be defined as personal data relating to the genetic characteristics of an individual which have been inherited or acquired as they result from an analysis of a biological sample from the individual in question, in particular by chromosomal, deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) analysis or analysis of any other element enabling equivalent information to be obtained

Nevertheless there is no clear reference to the fact that genetic (and, in general, health-related) researches can’t be pre-emptively limited to specific processing since scientists work with microscopes and not with crystal balls.

The result is that every research project that deals with patient (and patient’s relatives) records might face enormous bureaucratic burdens every time a new path of study emerges from the current one.

Furthermore, the regulation says that:

Member States may maintain or introduce further conditions, including limitations, with regard to the processing of genetic data, biometric data or health data

In other words, then, we will likely face a flood of local regulation that will make harder to perform researches that save human life.

Sure, there will always be the possibility to challenge in court the letter of the law, claiming that no provision can be interpreted in such a way to endanger human life and that data protection, in constitutional terms, is a “lesser right” when compared to the right to health. But this takes time, money and an open-minded court.

In the meantime, scientists will either slow down their activities or risk to be taken in court.

Does it make sense?

Fay, online advertising’s goof and the information overload

In this post I’ve shown what happens when the advertising process slips out of control: a brand is associated to a wrong message because of the lack of attention to every single step of a campaign.

In other times this mistake would have had dire consequences for the advertising agency… accounts fired, campaign suspended and, maybe, public apologies. But today is (in)different.

Who will ever notice – let alone, remember – the misery exploitation associated with this brand (again, unbeknownst by its management)?

Who will take appropriate actions to avoid a similar mistake in the future?

Who cares?

This is one of the consequences of the information overload: be sloppy. After a couple of hours nobody will even remember about it.